HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Guerci Selected Research

Etoposide (VP 16)

7/2005Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
6/2003Therapy-related acute promyelocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Guerci Research Topics

Disease

7Acute Promyelocytic Leukemia
01/2006 - 06/2000
4Neoplasms (Cancer)
01/2022 - 06/2002
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2013 - 02/2003
2Anemia
05/2013 - 04/2009
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2005 - 06/2002
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2004 - 04/2002
2Infections
02/2003 - 06/2000
1Lung Neoplasms (Lung Cancer)
01/2022
1Cytopenia
04/2009
1Virus Diseases (Viral Diseases)
04/2005
1Polycythemia Vera
02/2004
1Thrombocytopenia (Thrombopenia)
02/2004
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
02/2004
1Edema (Dropsy)
01/2004
1Breast Neoplasms (Breast Cancer)
06/2003
1Refractory Anemia with Excess of Blasts (RAEM)
02/2003
1Renal Insufficiency (Renal Failure)
02/2003
1Hematologic Neoplasms (Hematological Malignancy)
02/2003
1Unstable Angina
02/2001
1Myocardial Infarction
02/2001
1Acute Coronary Syndrome
02/2001

Drug/Important Bio-Agent (IBA)

6Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2009 - 06/2000
2ErythropoietinFDA Link
05/2013 - 04/2009
2HematinicsIBA
05/2013 - 04/2009
2Mitoxantrone (Novantrone)FDA LinkGeneric
07/2005 - 06/2003
2Cytarabine (Cytosar-U)FDA LinkGeneric
07/2005 - 02/2003
2Etoposide (VP 16)FDA LinkGeneric
07/2005 - 06/2003
2AnthracyclinesIBA
06/2003 - 02/2003
1CopperIBA
01/2022
1CollagenIBA
01/2022
1GelsIBA
01/2022
1Buthionine SulfoximineIBA
01/2022
1SulfonamidesIBA
01/2022
1Filgrastim (Neupogen)FDA Link
05/2013
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2013
1Darbepoetin alfa (Aranesp)FDA Link
05/2013
1enhanced green fluorescent proteinIBA
04/2005
1Insulin (Novolin)FDA Link
04/2005
1Heparin (Liquaemin)FDA LinkGeneric
02/2004
1danaparoid (Orgaran)FDA Link
02/2004
1bcr-abl Fusion ProteinsIBA
01/2004
1Imatinib Mesylate (Gleevec)FDA Link
01/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2004
1Type II DNA Topoisomerases (Topoisomerase II)IBA
06/2003
1Antineoplastic Agents (Antineoplastics)IBA
02/2003
1Irinotecan (Camptosar)FDA LinkGeneric
02/2003
1DNA (Deoxyribonucleic Acid)IBA
02/2003
1InterferonsIBA
04/2002
11- arabinofuranosylcytosine- 5'- stearylphosphateIBA
04/2002
1Platelet Membrane GlycoproteinsIBA
02/2001
1Glycoproteins (Glycoprotein)IBA
02/2001
1Platelet Membrane Glycoprotein IIbIBA
02/2001
1Eptifibatide (Integrilin)FDA Link
02/2001

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2006 - 06/2000
4Therapeutics
07/2005 - 06/2000
3Stem Cell Transplantation
07/2005 - 06/2000
2Radiotherapy
06/2003 - 06/2002
1Salvage Therapy
01/2005
1Percutaneous Coronary Intervention
02/2001